Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional del IPN Unidad Durango, Durango, México.
Pharmacology. 2010;86(1):30-6. doi: 10.1159/000314334. Epub 2010 Jun 30.
The aim of this study was to explain the variability of CYP2D6 activity by the identification of CYP2D6 deletion and multiplications, and the single-nucleotide polymorphisms (SNPs) -1584C-->G, 31G-->A and 2988G-->A in Mexican Mestizo and Tepehuano subjects. One hundred twelve Mestizos and 99 Tepehuano Amerindians were studied, who were previously phenotyped with dextromethorphan. The frequencies of CYP2D6*2A [-1584C-->G] and *35 [-1584C-->G, 31G-->A] were 10.7 and 4.1%, respectively, in Mestizos, which is evidently a trend towards an extensive metabolism in carriers of the -1584G change. In Tepehuanos, *2A was identified with a frequency of 20%, and the allele 35 was not found. The frequencies of CYP2D65 (deletion) and *41[2988G-->A] were 1.3 and 2.2% in Mestizos and 0.5 and 1% in Tepehuanos, respectively. The SNP 2988A was found to be significantly related with the intermediate metabolizer phenotype in Mestizos (R = 0.309; n = 88; p = 0.006). The multiplications had frequencies of 4.1% in Mestizos and 1.5% in Tepehuanos. Only in the Mestizos did the presence of multiplications significantly decrease the DM/DX (dextromethorphan/dextrorphan) values (R = 0.273; n = 88; p = 0.016). The polymorphisms studied had different frequencies between Tepehuanos and Mestizos (p < 0.001); however, in the Tepehuano group these had a low influence on their phenotypic expression. It helps to understand the genotype-phenotype relationships of CYP2D6 in our studied populations.
本研究的目的是通过鉴定 CYP2D6 缺失和倍增,以及单核苷酸多态性(SNP)-1584C-->G、31G-->A 和 2988G-->A,来解释 CYP2D6 活性的变异性。我们研究了 112 名梅斯蒂索人和 99 名特佩胡阿诺美洲印第安人,他们之前曾用右美沙芬进行表型检测。在梅斯蒂索人中,CYP2D62A[-1584C-->G]和35[-1584C-->G,31G-->A]的频率分别为 10.7%和 4.1%,这显然是携带-1584G 突变的广泛代谢的趋势。在特佩胡阿诺人中,2A 的频率为 20%,未发现等位基因35。CYP2D65(缺失)和41[2988G-->A]的频率在梅斯蒂索人中分别为 1.3%和 2.2%,在特佩胡阿诺人中分别为 0.5%和 1%。SNP 2988A 与梅斯蒂索人中的中间代谢表型显著相关(R = 0.309;n = 88;p = 0.006)。在梅斯蒂索人中,倍增的频率为 4.1%,在特佩胡阿诺人中为 1.5%。只有在梅斯蒂索人中,倍增的存在显著降低了 DM/DX(右美沙芬/右甲吗喃)值(R = 0.273;n = 88;p = 0.016)。在所研究的人群中,特佩胡阿诺人和梅斯蒂索人之间的多态性频率存在显著差异(p<0.001);然而,在特佩胡阿诺人群中,这些多态性对其表型表达的影响较低。这有助于我们理解研究人群中 CYP2D6 的基因型-表型关系。